Which companies overlap with Nanogen Pharmaceutical Biotechnology Joint Stock Company's portfolio?

Top competitors by shared drug class: , Alexza Pharmaceuticals, Inc., Alza Corporation, DE, USA, Assistance Publique Hopitaux De Marseille, Eli Lilly and Company.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/nanogen-pharmaceutical-biotechnology-joint-stock-company.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Nanogen Pharmaceutical Biotechnology Joint Stock Company — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Nanogen Pharmaceutical Biotechnology Joint Stock Company pipeline: 0 marketed, 0 filed, 4 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 4 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Area
Nanocovax	Nanocovax	phase 3		Other
pegcyte	pegcyte	phase 3		Other
Faceptor	Faceptor	phase 3		Other
Stimus (NNG-DEPO)	Stimus (NNG-DEPO)	phase 3	Central nervous system stimulant	Neurology

Therapeutic area mix

Other · 5
Neurology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

· 1 shared drug class
Alexza Pharmaceuticals, Inc. · 1 shared drug class
Alza Corporation, DE, USA · 1 shared drug class
Assistance Publique Hopitaux De Marseille · 1 shared drug class
Eli Lilly and Company · 1 shared drug class
Impax Laboratories, LLC · 1 shared drug class
Janssen-Cilag International NV · 1 shared drug class
McMaster University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Nanogen Pharmaceutical Biotechnology Joint Stock Company:

Cite this brief

Drug Landscape (2026). Nanogen Pharmaceutical Biotechnology Joint Stock Company — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/nanogen-pharmaceutical-biotechnology-joint-stock-company. Accessed 2026-05-18.